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INTRODUCTION
Microorganisms are capable of repairing the damage to D
induced by the monofunctional alkylating agent, methyl methane-
sulfonate. Little is known about the nature of this repair, but
most of the data are consistent with a model for the repair of
UV-induced DNA damage. Since UV repair has been studied exten-
sively, this model has been used as a basis for describing repair
of damage to DNA caused by other agents.
The model of excision and repair for UV-induced DNA damage
is described as follows:
1. Recognition of the pyrimidine d liners by an endonuclease
which breaks DNA near the site of the dimers.
2. Removal of damaged bases along with an unspecified portion
of the same strand of DNA.
3. Repair replication by a polymerase enzyme which resyn-
thesizes the portion of the strand which has been removed.
k, A patching operation which covalently links the free end
of the newly-synthesized DNA to the "old" DNA strand,
completing the sugar-phosphate backbone.
Data suggest that damage to the DNA of microorganisms caused
by ionizing radiation, Mitomycin C, and bifunctional alkylating
agents can be repaired in a manner which is consistent with this
excision-repair mechanism. The repair of DNA damaged by all of
these agents can be explained utilizing either part or all of the
steps involved in excision-repair. If all of the steps are required
2for repair of damage Induced by a particular agent (such as
Mitomycin C or a bifunctional alkylating agent), a UV-sensitive
mutant is sensitive to this arent also. If only the latter steps
of excision-repair are required for repair of damage induced by
a particular arent (such as Ionizing radiation which causes single-
strand breaks in DNA, for example) a UV-sensitive mutant may be
capable of repairing this particular type of damage.
If Bacillus subtilis 168H is treated with methyl methanesulf o-
nate and subsequently incubated in a growth medium, there is an
increase in the transforming activity of DNA from these cells
compared to DNA from MMS-treated cells which are lysed immediately
Reiter and Strauss, 1965). This indicates there is a repair
mechanism in 3. subtilis for MMS-induced DNA lesions. There is
evidence in support of the hypothesis that NHS repair occurs via
the steps of the excision-repair mechanism. Solubilization of
DNA occurs if cells are incubated in growth medium after MMS
treatment (Searashi and Strauss, 1967). These cells incorporate
3H-thymidine in a nonconservative fashion (i.e., repair replication)
with concomitant increase in transforming activity (Reiter and
Strauss, 1965).
There are two lines of evidence that this repair is slightly
different from the repair of UV-induced lesions in DNA. UV-
sensitive cells are capable of repairing the NNS-induced lesions
in DNA. MMS causes single-strand breaks in DNA (Strauss and Wahl,
196^1-). It is possible that repair of NNS-induced damage, similar
to the repair of damage due to ionizing radiation, requires only
3i latter steps of excision-repair. This hypothesis is consistent
ith the evidence that KM3-sensitive mutants are also UV-sensitive.
To he sensitive to KMS a mutant would have to be defective in a
later step of repair. This mutant would still be sensitive to
UV, in spite of the fact that it could excise prymidine dimers,
since UV repair requires all of the steps in the excision-repair
mechanism. Therefore, recovery of MMS-induced lesions may be a
result of repair which differs from UV repair by at least one
step, but is consistent with the excision-repair mechanism in
fteneral.
Heiter and Strauss (1967) reported that MMS repair is differ-
ent from Uv repair in another aspect: repair of UV-induced damage
is inhibited by actinomycin, whereas repair of MMS-induced damage
apparently occurs in the presence of this antibiotic. The purpose
of this research was to attempt to elucidate this anomalous
feature of MKS repair.
REVIEW OP LITERATURE
Removal of UV-Lnduced Lesions in DNA
by an Sxclsion-Repair Mechanism
There is an accumulation of evidence that the UV-induced
damage to DNA is a result of the formation of pyrimidine dimers.
cker (1963) was able to demonstrate that lesions were present
in DNA after UV-irradiation. At doses that are biologically
significant a relationship exists between survival and the amount
of thymine dimers present. These dimers are formed from adjacent
thymine residues present on the same strand.
UV photoproducts in addition to thymine dimers include cyto-
sine dimers and cytosine-thymine dimers (Setlow, Carrier and
Bollum, 1965). Gytosine moieties may also be desalinated, forming
uracil dimers or uracil-thymine dimers. The addition of water to
5,6 double bond of these bases frequently occurs (Smith, 1964).
The presence of pyrimidine dimers may cause a distortion of the
DNA twin helix and local interruption of the hydrogen bonding
between base pairs (Setlow, 1966).
It was first recognized that microorganisms are capable of
altering the effects of UV light when mutants were isolated with
sensitivities toward UV that are different from the wild types
(Witkin, 194?; Hill, 1953). A photoreactivation enzyme (Wulff
and Rupert, 1962 ) which splits pyrimidine dimers (Setlow and
Setlow, 1963; Setlow, Boling and Bollum, 1965) is capable of
rreversing at least $0$ of the lnactivatloh of transform!? L ..
at hi -h doses of UV radiation (Setlow and Setlow, 1962 j
1964). Immediately after UV-irradiation, if cells are incubated
in growth medium, there is a delay in DNA synthesis vrhlch is pro-
portional to the dose (Hanawalt and Setlow, i960). Studies or. the
rate of synthesis of DNA in vitro indicate that the primer activity
of DNA is affected by UV light and part of this damage is cue to
the formation of thymine dimers (Solium and Setlov:, I963).
Although both UV-sensitive and UV-resistant cells produce the
same number of dimers (Setlow, Swenson and Carrier, I963), UV-
resistant cells are capable of excising thymine dimers during the
period when net DNA synthesis does not occur (Setlow and Carrier,
1964; 3oyce and Howard-Flanders, 1964). Thymine dimers are not
excised per se but are still attached to the phosphodiester back-
bone (Boyce and Howard-Flanders, 1964). The actual size of the
fragments excised cannot be determined since random breakdown by
nucleases may occur after excision. DNA synthesis in UV-sensitive
cells which are unable to excise thymine dimers is permanently
inhibited by low doses of UV light (Setlow and Carrier, 1964;
Boyce and Howard
-Flanders, 1964). In these mutants one dimer may
act as a permanent block to DNA synthesis (Swenson and Setlow, i960)
Petti john and Hanawalt (1964) demonstrated that nonconservative
replication occurs during the period when there is no net D
synthesis and DNA degradation is occurring. This nonconservative
DNA synthesis may occur at random over the bacterial genome and
is not restricted to DNA either in front of or behind the
6replication growing point.
UV-sensitive mutants of Escherichia coli K-12 which control
excision of thymine dimers have been mapped at three sites on
the bacterial chromosome (Howard-Flanders, et al, 19^2; Putte,
et al
, 1965). The gene products from these loci do not act in
any sequence (Howard -Flanders, Boyce and Theriot, 1965).
From these results it was concluded that DMA synthesis is
prevented by the presence of UV photoproducts, such as thymine dimers.
Cells can repair the UV-induced DNA damage by the excision of pyrlm-
idine dimers. This is accompanied by further degradation of DMA
and local resynthesis, which occurs by the insertion of new bases
pairing with the bases of the opposite strand. If the repair poly-
merase is identical to the Kornberg enzyme, this synthesis occurs
by the addition of a 5' trinucleotide to a 3' OH end of the DNA
strand (Chargaff and Davidson, i960). This last step of repair
requires that newly-synthesized DNA be joined to the old part of
the same strand to complete the phosphodiester backbone. Recent
investigations (Gellert, 1967; Weiss and Richardson, 1967) have
demonstrated the existence of an enzyme capable of catalyzing the
repair of single-strand breaks with the formation of covalent 3 '-5'
phosphodiester bonds.
Repair of Other DNA Lesions by an
Excision-Repair Mechanism
The model of repair proposed for UV damage (Setlow and Carrier,
1964; Boyce and Howard
-Flanders, 1964) has been expanded to include
repair of damage by other agents (Kayr.es, I966). U7 light, bi-
functlonal alkylating agents, and Mitomycin C compose a class of
agents which damage DNA. This damage probably requires all the
steps in the excision-repair mechanism for recovery. These agents
affect the DMA molecule by altering its structure In some way.
Bifunctional alkylating agents such as nitrogen mustard or mustard
gas are capable of forming cross-links in DNA by alkylating the
N7 position of guanine in adjacent base pairs, if the guanine moieties
occur in opposite strands of the DNA molecule (Brookes and Lawley,
1961 ; Lawley and Brookes, 1963, 1965).
UV-sensitive cells are sensitive to nitrogen mustard, whereas
UV-resistant cells are resistant (Haynes, Patrick and Baptist, 19640.
Kohn, Steigbigel and Spears (1965) showed that UV-resistant cells
treated with nitrogen mustard are capable of repairing cross-links
in their DNA during incubation in growth medium after treatment.
DNA synthesis in these cells is only slightly affected after treat-
ment. In contrast, UV-sensitive cells cannot remove cross-links
during post-treatment incubation, and DNA synthesis is completely
inhibited. In wild type cells nonconservative repair replication
occurs during the incubation period after treatment with nitrogen
mustard (Hanawalt and Haynes, 1965).
When microorganisms are treated with sulfur mustard, DNA
degradation occurs. The rate of loss of sulfur mustard products
that are initially bound to DNA is greater than the rate of overall
DNA degradation. Several products including mono- and bifunctionally
alkylated guanine are eliminated. After a lag, treated cells re-
cover the capacity to synthesize DNA (Papirmeister and Davison, 196^).
8In UV-sensitive strains DM synthesis is inhibited, but the ?*S
from the sulfur mustard treatment is not removed. In contrast,
resistant strains are capable of enzymatically degrading DM
during the inhibition of DM synthesis with the release of 50%
of the
-'^S. Both strains are alkylated to the same extent.
During one hour of post-treatment incubation in growth medium,
resistant cells are capable of removing all di- and most mono-
functionally alkylated guanine residues (Lawley and Brookes, 1965).
Lovelace, Cook and Wheatley (I965) have shown that cells are
also capable of recovery after treatment with mustard gas.
Mitomycin C also fonus covalent cross-links in the comple-
mentary DM strands. Although the exact site of interaction on
the DM molecule is not known, work with space-filling models is
compatible with interstrand linking between the amino group of
adenines or cytosines, or between the 06 groups of guanine moieties,
Correlation of cell death with GC content favors either C— C,
C-C or G-C cross-links (Iyer and Szybalski, 196^; Szybalski and
Iyer, 196^). UV-resistant cells treated with Mitomycin C are
capable of removing cross-links in DM, whereas most UV-sensitive
cells are not (Terawahi and Greenberg, 1966; Mahler, I966). The
DM of cells which have been treated with Mitomycin C is degraded
after treatment (Reich, Shatkin and Tatum, 1961).
These results certainly suggest that the same mechanism of
excision and repair proposed for UV damage may be operating in
cells after treatment with bifunctional alkylating agents and
Mitomycin C. Cells which are able to excise thymine dimers are
9also capable of excising cross-linked, alkylated guanine resid i
and removing cross-links caused by Mitomycin C. Cells which can-
not excise thymine dimers are deficient in these functions also.
Repair of DNA Containing Single-Strand Breaks
A second class of agents which induce DNA damage include
ionizing radiation, 3 P decay, and monofunctional alkylating agents.
These agents all cause single-strand breaks, among other types of
damage, in the DNA molecule.
Since UV-sensitive cells are sensitive to bifunctional alky-
latin- agents and Mitomycin c, it is interesting to determine if
they are also sensitive to ionizing radiation. One of the major
lesions from ionizing radiation at biologically significant doses
is single-strand breaks (Shooter, 1957; Freif elder, 1965, 1966).
It may be possible that some UV-sensitive mutants can be X-ray
resistant even though they lack the excision enzyme, if they are
capable of degrading and resynthesizing damaged DNA.
Rorsch, Edleman and Cohen (1963) mapped a gene in 2. coli (hrr~)
that controlled X-ray sensitivity, as well as UV sensitivity. S.
0011 Bs-1» which is UV-sensitive and lacks the ability to excise
thymine dimers, is more sensitive to ionizing radiation than E.
coli B/r (Hill and Slmson, I96D. The initial rate of enzymatic
degradation of DMA is the same for 3
S _ 1 and B/r, but eventually
3s-l suffers two to three times as great a loss. Three times as
much X-irradiation is required to produce the same reduction of
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incorporation of ^H-thymidine in B/r as in 3S _1 (KcGrath, Williams
and Swartzendruber, 1966). B/r is capable of repairing single-
strand breaks caused by ionizing radiation, but Zs _i cannot (KcGrath
and Williams, 1965). Since E. coli 2S _X is a double mutant (Kattern,
van Wir.den and Rorsch, I965), it is apparently defective in a later
step of the excision-repair mechanism, as well as defective in its
ability to excise thymine dimers. It is sensitive to both KMS and
nitrogen mustard; repair does not occur even though breaks may
already be present in the DMA (Bridges and Munson, I966). There
is a synergistic interaction between UV radiation and X-rays in
B/r, which also implies that the same repair mechanism is effective
in the recovery from both types of damage (Haynes, 19640.
UV-sensitive organisms that are X-ray resistant have also
been isolated. Bridges and Munson (1966) isolated a UV-sensitive
mutant, E. coli HP2 her , which lacks the ability to excise thymine
dimers but is no more sensitive to ionizing radiation than 3/r.
This mutant is also sensitive to nitrogen mustard but not to methyl
methanesulfonate, which causes single-strand breaks in DNA (Strauss
and '.Ja.hl, 1964; Wahl, 1965). Another UV-sensitive mutant of E.
coli K-12 which cannot excise thymine dimers (Boyce and Howard-
Flanders, 1964) is capable of degrading DNA that has been X-irradi-
ated to the same extent as the wild type (Emmerson and Howard-
Flanders; 1965). .These data are consistent with the hypothesis
that the degradation step in repair, which requires a break in
the phosphodiester backbone of one strand, is separated from the
excision step, which causes single-strand breaks in the DM molecule.
11
E. coll WP12 her" and E. coli K-12 uvr" lack the endonuclease
capable of causing interruptions in the backbone, but they are
still capable of repairing daiiage from agents -which produce single-
strand breaks in DM. Loci which are defective for excision are
not necessarily defective for degradation.
32
P causes single-strand breaks in DMA by transmutations
(Strauss, 1958). Cairns and Davem (1966) have found that DNA
synthesis is delayed slightly in normal cells after heavy labeling
32
with " P but ceases immediately in rec (UV-sensitive) strains.
Degradation of DNA occurs to the same extent that DNA synthesis
has been reduced, but it is not restricted to the part of the
chromosome containing the ^ P label. In other words, post-treat-
32
ment behavior of microorganisms after P labeling is very similar
to that occurring after UV- or X-irradiation. Kutants sensitive
32
to UV light and X-ray are also more sensitive to P decay, whereas
resistant mutants are less affected by this treatment than wild
types (Hill and Simson, 1961)
.
In conclusion, damage induced by agents which cause single-
strand breaks in DM may be repaired by utilizing the latter
steps of the excision-repair mechanism. Therefore, UV-sensitive
mutants defective in the first steps of this mechanism are still
32
able to repair damage caused by ionizing radiation, MS, and ?,
but not damage cuased by bifunctional alkylating agents or Mito-
mycin C. Mutants which are defective in a later step of excision-
repair are unable to repair either type of damage.
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The Relationship of Recombination
and Excision-Repair
One of the current models for recombination envisions a break-
ing and rejoining of the particular chromosomes involved. This
phenomenon may occur by the same mechanism of excision and repair
which results in the removal of DNA lesions. Mutants which are
unable to form recombinants, although DNA is taken up by the cell,
are also UV sensitive (Clarke and Kargulies, 1965). In B. subtllis
.
Mitomycin C and UV sensitivity are controlled by a single genetic
event and are directly associated with the cell's ability to under-
go recombination (Okubo and Romig, 1966).
A recombination-deficient mutant of E. coli K-12, which is
UV-sensitive in spite of the fact that it is capable of excising
thymine dimers, is also sensitive to ionizing radiation. DNA
degradation after exposure to UV light occurs at a tremendous rate
(Howard-Flanders and Theriot, 1966). Apparently this particular
mutant is unable to regulate the breakdown and resynthesis of DNA
during excision-repair. However, another UV-sensitive rec" mutant
which has an intermediate sensitivity to- ionizing radiation under-
goes normal DNA degradation after exposure to UV light (Howard-
Flanders and Boyce, I966).
Van de Futte, Zwenk and Rorsch (1966) have mapped four rec"
mutants which were UV-sensitive, X-ray sensitive, and hcr + at
three different sites on the bacterial chromosome. The nuclease
activity in these mutants is no different from wild type. Two rec~
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mutants are also able to form covalent links at the site of single-
strand breaks at the same rate as the normal cells (Gellert, 196?).
Although the phenomenon of recombination is not completely
understood, it can be concluded that it is related to excision and
repair.- Recombination requires the latter steps of this mechanism
only. This is similar to the repair of DM damage induced by
agents which cause single-strand breaks in the DM molecule.
Repair of MMS-Induced DM Damage
Lawley and Brookes (I963) have shown that methyl methane-
sulfonate (fflS) causes damage to DM by alkylating the nucleo-
philic centers in the DM molecule at the N7 of guanine and more
slowly at the N3 of adenine.' Alkylation of the Nl position in
adenine is suppressed because of its involvement in hydrogen bond-
ing. Upon alkylation, a quaternary nitrogen is formed, depleting
the electrons in the ring structure of the alkylated base. This
causes a destabilization of the alkylated moieties. Apurinic sites
may then appear if hydrolysis occurs (Lawley and Brookes, 1963).
Further hydrolysis at the phosphodiester bonds adjacent to the
apurinic sites result in single-strand breaks (Strauss and Wahl,
196^).
A series of mutants of B. subtilis with sensitivities analogous
to those in E. coli have been isolated. These mutants behave in
a manner which is in agreement with the model of excision-repair.
Since B. subtilis can be transformed, it is possible to use this
organism to assay for biological activity DNA treated in vario
vs
.
An enzyme present in Micrococcus Iysodei>ticus extracts is
capable of inactivating and degrading DMA treated with UV light
or MM3 (Strauss, 1962; Strauss, Searashi and Bobbins, i960),
similar enzyme in 3. subtili s is capable of inactivating E
treated with MHS but not with UV light (Reiter and Strauss, 1965).
UV-sensitive mutants are unable to repair UV-induced lesions
as measured by a continued sensitivity of the extracted DM/i to the
H« lysodaifcticus extract when treated cells have been incubated
prior to lysis (Strauss, Searashi and Bobbins, 1966). Absence
of repair can also be measured by a lack of increase in the trans-
forming activity of DMA extracted from UV-treated, incubated cells
to be transformed by UV-irradiated transforming DNA (Strauss,
Searashi and Bobbins, 1<?66), and by an inability of UV-irradiated
phage SP01 to survive on a UV-sensitive host (Reiter and Strauss,
I965}. UV-resistant cells solubilize DMA after UV treatment, but
UV-sensitive cells do not (Strauss, Reiter and Searashi, I966).
UV-sensitive mutants are able to recover from HMS-induced
damage. This is measured by an increase in extractable trans-
forming activity of EMS-treated cells which have been incubated
in medium and by an ability of HMS-treated SP01 phage to survive
or these UV-sensitive cells (Reiter and Strauss, I965).
In contrast, mms strain is sensitive to UV light and cannot
support growth of either UV- or MMS-treated SP01 (Searashi ard
Strauss, 1965; Strauss, Reiter and Searashi, 1966). This mutant
JO
degrades its DNA after UV treatment to a greater extent than nor-
1 cells do. After MMS treatment even more DNA breakdown occurs
(Searashi and Strauss, 1967). The mms " strain is poorly trans-
formed compared to the UV-resistant or UV-sensitive strains
(Strauss, Reiter and Searashi, I966).
Repair replication similar to that occurring In E. coli treated
with UV light (Petti john and Hanawalt, 196*0 occurs in 3. subtilis
uvr ' treated with MMS (Reiter and Strauss, 1965). If H1 ^;. density-
labeled cells are treated with MMS and then incubated in H ) med-
3ium with H-thymidine, incorporation of radioactivity is accompani-
ed by an increase in transforming activity at the position of the
"old" (heavy) DNA as determined in CsCl density, gradients.
Since there is a nuclease present in B. subtilis which degrades
DNA containing MMS induced lesions at the time of lysis, it is pos-
sible to measure recovery of MMS-lnduced damage as an increase in
extractable transforming activity from incubated cells compared to
MMS-treated cells lysed immediately (Reiter and Strauss, 1965). Re-
covery may also be determined by measuring an increase in molecular
weight of DNA extracted from incubated cells compared to that of
MMS-treated cells lysed immediately (Reiter, Strauss, Robbins and
Marone, 196?). If cells are prelabeled with radioactive thymidine,
DNA from recovered cells appears in an intermediate position in
sucrose gradients between DNA from untreated cells and DNA from
MMS-treated cells which have been lysed immediately. Transform! 1
activity is found at the position corresponding to the radio-
active peak for each DNA sample. If cells are labeled during the
recovery period, transforming activity and newly-incorporated
label of recovered cells again occurs at a position intermediate
16
of the transforming activity of control and unrecovered DKA samples.
The above data suggest that MMS recovery is similar to repair
except that it may require one less early step in repair, as seen
by the resistance of UV-sensitlve cells to MMS and the sensitivity
of mms" mutants to UV light as well as to MMS. It is similar since
nonconservative repair replication occurs and some DMA is solu-
bilized in the process. Apparently the excision step is not re-
quired for MMS repair since the UV-sensitlve strain can repair MMS-
induced damage. The mms" strain must be deficient in a later step
in repair since it cannot repair either UV- or MMS-induced damage.
Reiter and Strauss (19&7) have shown that MMS repair seems to
differ from UV repair in at least one other characteristic. Actin-
omycin inhibits repair of UV damage. The DKA from UV-irradiated
cells incubated in growth medium plus actinomycin remains suscept-
ible to the Mi lysodeikticus enzyme. There is a lag in the solu-
bilization of DMA in these cells during the incubation period after
treatment which is equivalent to the period required for DKA to be-
come resistant to the M. lysodeikticus enzyme in the absence of ac-
3tinomycin. H-thymidine added at the time of incubation after UV
treatment is not incorporated in the presence of actinomycin. Ac-
tinomycin may be preventing repair replication, or the need of rep-
lication if it is preventing excision from occurring. Whatever
mechanism of inhibition is being utilized, it seems to be avoided
in the repair of MMS-induced damage, if MMS-treated cells are
incubated in growth medium plus actinomycin, there is an increase
in extractable transforming activity compared to the DM extracted
from MMS-treated cells which have been lysed immediately after
treatment. Thus, it appears that cells are able to repair MMS-
damaged DKA in the presence of actinomycin.
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The Effects of Actinomycin on E ..
Actinomycin binds to the N2 amino group of the guanine moiety
in the double-stranded, helical DNA molecule (Ceraml, Reich, Ward
and Goldberg, I967). The bound actinomycin molecule lies in the
minor groove of the DNA molecule (Reich and Goldberg, 1964). The
quinoldal oxygen, the amino group, and the intact peptide lactones
of actinomycin are required for this completing to occur (Ceraml,
et al, 1967).
Actinomycin does not inhibit alkylation of the guanine by
mustard gas or other alkylating agents (Ceraml, ejb al, I967).
When actinomycin forms complexes with native DNA, the spectrum of
the antibiotic changes (Goldberg, Habinowitz and Reich, 1966), the
bouyant density of the DNA is decreased (Kersten, Kersten and
Szybalski, I966), and the thermal stability of the DNA molecule
is increased (Haselkorn 1964: Reich, 1964). In microorganisms
RNA synthesis is inhibited at much lower concentrations of acti-
nomycin than DNA synthesis (Reich and Goldberg, 1964). Evidence
suggests that actinomycin is capable of replacing RNA polymerase
in the minor groove and hindering the function of DNA polymerase
by changing the physical characteristics of DNA (Reich and Goldberg,
1964). The actinomycin-DNA complex is fairly stable (Reich and
Goldberg, 1964). The association may be reversed by 5 M urea,
and the actinomycin may be extracted with ether (Hartman, Coy and
Kniese, I963).
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MATERIAL AND METHODS
a. Bacterial Strains
bacillus subtilis 168H ind + thy", a UV-sensltive mutant of
168M which requires thymidine for growth, was the major organism
used in this investigation. B. subtilis //^o mms"lnd+thy~, an MKS
—
'
'
III! I — I -
I
* *
sensitive mutant of 168M also requiring thymidine for growth, was
used in some experiments. B. subtilis 168H lnd~
, which requires
tryptophan for growth, was used as a recipient In transformation
experiments. This organism was also used as a source of an enzyme
extract.
b. Culture Media
SS(a minimal salts medium composed of (NH^^SOj, (2.0gm),
K2HPO4 (14.0 gm), KHgPO^ (6.0 gm), sodium citrate (1.0 gm), and
MgS0jfj,*7H2 (0.2 gm) in a total volume of one liter) was used for
all cell dilutions. CH (minimal salts medium containing a final
concentration of 0.5$ glucose and 0.0^;£ casein hydrolysate) , CHT^q
(minimal salts medium containing a final concentration of 0.5$
glucose, 0.04;! casein hydrolysate, and 50A?/al of tryptophan), or
CHT^ (minimal salts medium containing 0.5$ glucose, 0.02$ casein
hydrolysate, and 5 /*g/ml of tryptophan) were used as growth media
in all experiments.
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Transformants were assayed on CH plates (minimal salts
plus 15 "in of Bacto-agar per liter of de-ionized water con-
taining a final concentration of 0.5/i ."iucose and 0.0^/> casein
hydrolysate) . Cell counts were made on N3S plate." (nutrient
agar plates supplemented, with 0.5/ ""lucose and minimal salts).
3HI (3? gm of brain heart infusion plus 15 gm of Bacto-arar
per liter of de-ionized water) or TBAB (33 gm of tryptose
blood agar base per liter of de-ionized water) were used to
plate cells for overnight growth as a source of inocula.
c. Chemicals
Kethyl methanesulfonate ( MI-IS ) from Eastman Organic Chemicals
was vacuum-redistilled before use. If necessary, the HKS was
diluted immediately before use in 0.05 M phosphate buffer
(pH 7.^-). Actinomycln D, a gift from Merck, Sharpe and Dohme,
was first dissolved in absolute alcohol and then diluted to the
desired concentration with distilled water.
d. Procedure for Transformation Experiments
3. subtilis 163H ind ~ was grown overnight on either a BHI or
a TBAB plate. In the morning a heavy inoculum from the plate was
added to 10 ml of CHT^q and mixed well. The cells were aerated
by bubbling air through the medium for four hours at 37 0. A 10
dilution was made into CKT^, and aeration was continued for 90
minutes. At this time 0.9 ml of these competent cells was quickly
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added to 0.1 ml of transforming DNA in a test tube 14 nra in
diameter. The cells were shaken vigorously for 3 r-> minutes
37 C, then diluted in SS and plated on CH for an assay of the
number of transforraants present. x£ach dilution was plated ir.
duplicate, and an average of the two counts was used.
e. The effects of Actinomycln on Transformation
Competent cells were prepared by addinr 5.0 ml of CHTcq to
an overnight culture of B. subtilis 163H lnd ~ on a BHI plate.
Cells were scraped from the agar and suspended in the CKTVq.
0.15 ml of this cell suspension was added to 5.0 ml of CHT*q and
aerated for four hours at 37 C. 1.0 ml of this culture was then
added to 9.0 ml of CHT* and aerated for 90 minutes. At this tine
0.9 ml of these competent cells was added to each of seven tubes
containing the following in 0.1 ml volumes:
#1 8.0^g of DNA from B. subtilis W23 ird + .
#2 S.O^xg of DNA + 200^5 of DNase added 15 minutes before
the competent cells were added.
#3 8.0 ms of DNA + 200 m-z of DKase added at the same time
as the competent cells.
#4 8.0 js? of DNA + 200 >*£ of DNase added 3 minutes after
the competent cells.
#5 B.0^ of DNA + 1.6 MB of actlnomycin added at the same
time as the competent cells.
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'/6 8.0>tg of DNA + 1.6 ^.r of actinomycin added 3 minutes
after the competent cells.
/'? 8.0 .^g of DNA + 1.6 j*& of actinomycin added 10 minutes
after the competent cells.
The tubes were shaken vigorously for 30 minutes at 37 C.
—1 —2
0.1 ml, 10 , and 10 dilutions of each were plated on CH to assay
for the number of trans formants.
In another experiment, actinomycin was added to cells before
they were lysed. These lysates were then assayed for transforming
activity. The protocal was as follows:
j. _
B. subtilis 168H ind thy was grown overnight in CH medium
+ 10 ^tg/ml of thymidine. 0.2 ml of this culture was added to
10 ml of CH + h ,4/g/ml of thymidine and aerated for five hours at
37 C. These cells were collected on a membrane filter, resuspended
in 2k ml of CH and aerated for 10 minutes at 37 C. Three 2.0 ml
samples were removed and added to each of three centrifuge tubes
containing 2.0 ml of ice cold S3. The cells were centrifuged in
the cold. One sample was resuspended in 1.0 ml of 0.01 K tris + 0.01
M EDTA (pH 8.3). Another sample was resuspended in 1.0 ml of the
tris-EDTA buffer containing. 10.0 ^s of actinomycin, and the last
sample was resuspended in the same buffer containing 2.7 ^v~g of
actinomycin. The cells were lysed with 50 «*Ag/ml of lysozyme for
15 minutes at 37 C/ 100 M?,/ml of pronase was added for 10 minutes
at 37 C. Finally, 0.05 ml of 1% Duapnol was added. Without
—1
—2 —1 —h,further purification 10
, 10 , 10 J and 10 dilutions of these
lysates were assayed for transforming activity as described in
Section d, p 19.
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f. Survival Curves
_2
A 10 dilution of an overnight culture of B. subtilis 168H
ind thy or B. suhtills /y^O mms ind thy vras aerated for three hours
at 37 C in CHT^- + 1° >og/ml of thymidine. Cells were centrifuged,
washed, and resuspended in SS + 10 xv/ml of thymidine to a final
B
concentration of 1 x 10' cells /ml. The culture was bubbled for
5 minutes at 3? ~. At minutes a sample was removed for an assay
of viable cells, and MMS to a final concentration of 0.025 K or
0.05 M was added. At 2, 5, 10, 15 and 20 minute samples were re-
moved, diluted, and assayed for viable cells in duplicate on
NBS plates
.
g. Extraction Procedure for
B. subtilis Snzyme
Three liters of an overnight culture of B. subtilis 168H in
nutrient broth + 0.5/= glucose was centrifu^ed, washed with 0.5,*
KaCl + 0.5.0 KCi, and resuspended on 80 ml of 0.05 M tris +10
K EDTA buffer (pH 7.5). The cell suspension was incubated with
50 mg of crystalline lysozyme in 10 ml of the same solution for
30 minutes at 3? C. The lysate was cooled and sonicated with a
Bronson sonifier, Model 3-75, in 10 to 15 second pulses with in-
termitent cooling for a total of 3 to 4 minutes, or until there
was a decrease in viscosity. 10 ml of a 10/* solution of strep-
tomycin sulfate in 0.05 M phosphate buffer (pH 7 A) was added very
slowly with stirrinr over a period of or.e hour. The precipitate
was removed by centrifunation in the cold at 16,000 rpm for 30
minutes using a refrigerated Servall certrifwe. Also in the cold,
48 gm of ammonium sulfate vras added slowly, with gentle Stirring
to avoid foaming, to the supernatant over a period of one hour.
The precipitate vras collected by cold centrifugation at 16,000 rpm
for 15 minutes and dissolved in 20 ml of 0.05 M phosphate buffer
(pH 7.4). Two mlllititer quantities were stored at -15 G until
used, at which time one of the fractions was thawed at room temper-
ature.
h. DNA Treated With MMS In Vitro ;
General Procedure
DNA from 5. subtilis 168M tryp+
, purified by the Karaur pro-
cedure and redissolved in SS, was diluted in 0.05 M phosphate buf-
fer (pH 7.4) to a final concentration of 400 .^g/ml. One half of
the DNA was treated with 0.012 M MMS for 30 minutes at 37 C. Un-
treated and treated DNA samples were each divided into four equal
parts. 2.7 j+g/wl of actinomycin was added to two fractions of
untreated DNA and to two fractions of treated DNA. An equal volume
of S3 was added to the other two fractions of each. To one tube
containing actinomycin and to another tube containing S3, of both
treated and untreated DNA, an extract of B. subtilis vras added to
a final concentration which vras a 10~ dilution of the original
extract. A volume of S3 equal to the volume of extract vras added
to the two remaining tubes of each set. All tubes were incubated
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for 15 minutes at 37 C. 1$ Dupanol (sodium lauryl sulfate) was
T
added to a final concentration of 0.01$ to stop the enzyme re-
action. The reaction mixtures were diluted and added to competent
cells. In some experiments, actinomycin was incubated with DIIA for
15 minutes at 37 C before treatment with KMS.
When samples were to be centrifuped on sucrose gradients,
the same basic protocal was used as described above except the DNA
was labeled with -'H- thymidine. Actinomycin was added to one sam-
ple 15 minutes before treatment and to one sample immediately after
treatment with 0.05 M KKS. Immediately after enzyme treatment,
Dupanol was added, and 0.1 ml of each sample was carefully layered
on top of a sucrose gradient as described in Section k, p 26.
i. "DNA Treated With MMS In Vivo
General Procedure
B. subtilis 168H ind ' thy was grown overnight in CH + 10 ,^-s/ml
of thymidine. Cells vrere diluted 1/50 in fresh Ch + k _^-~/ml of
-5
thymidine + 4 >c/al of -'H-thymidine and bubbled for five hours at
37 C. At this tine they vrere collected on a membrane filter, washed
with CH, and resuspended in an equal volume of CH h- h ^-cg/ml of
thymidine. The cells vrere bubbled for 10 minutes at 37 C and assay-
ed for viable cells. Two samples were removed; one was added to
an equal volume of ice-cold SS and another to ice-cold 33 + 2.7
>tg/ml of actinomycin. 0.025 M MMS was added to the remaining cul-
ture. Cells vrere bubbled for 5 minutes, then chilled immediately
and assayed for viable cells. Two samples were quickly diluted into
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an equal volume of ice-cold SS, and two were diluted ir,to ice-
cold SS + 2.7^xo;/ral of actlnomycin. All of the samples were th
centrifuged in the cold. One MMS-treated sample was resu! led
CH + lO^ff/ml of thymidine. Another treated sample which had been
diluted in the presence of actlnomycin was resuspended in CH +
10 Mfrjral of thymidine + 2.7.^/ml of actlnomycin. :2oth of these
samples were bubbled at 37 C for 50 minutes and then centrifuged
in the cold. All samples which contained actlnomycin were re-
suspended in a small volume (1.0 to 1.5 ml) of 0.01 M tris buffer
containing 0.01 H EDTA (pH 8.3) + 2.7^<g/ml of actlnomycin. The
other samples were resuspended in the same volume of 0.01 M tris
buffer + 0.01 M EDTA (pH 8.3). The cells were lysed with a final
concentration of 50^r;/ml of lysozyme at 37 C for 15 minutes. A
final concentration of 100^g/ml of pronase was added for 10
minutes, then 0.05 ml of 1% Dupanol was added per ml of cell sus-
pension. These lysates were diluted 10" in order to be assayed
for transforming activity and centrifuged on sucrose gradients.
The same procedure was used for 3. subtilis #^0 mms "ind +thv"
except that 3H-thymidine was omitted, and the lysates were
analyzed for transforming activity only.
3. Dissociation of Actinomycin-DNA Complex
Lysates from an in vivo experiment were diluted 10
_1
in an
urea solution (48gm dissolved in 100 ml of distilled water and
brought to pH 8.3 with NaOH). Samples were mixed very slowly in
a shaker, waterbath at 37 C for 20 minutes. The actlnomycin was
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carefully extracted, to avoid shearing the DNA, four times with
anhydrous ethyl ether. Samples were dialyzed at room temperature
a -a in st 0.01 M tris + 0.01 M EDTA (pH 8.3) to remove the urea.
The samples were centrifuged on sucrose gradients as described
in the next section.
k. Sucrose Gradient Centrifugation
0.1 ml of each reaction mixture from an in vitro experiment
was carefully layered on a 5 ml, S-Ip to 17. 6/0 (w/w) sucrose grad-
ient in 0.1 ft phosphate buffer (pH ?.^). Samples were centrifuged
at 35.000 rpm (100,000 g) for two hours in a SW 50L rotor in a
Beckman, Kodel L-4, ultracentrifuge at 18 C. Seventeen drops per
fraction were collected from the bottom of the tube. Each frac-
tion was diluted with 0.5 ml of SS, and DNA was precipitated, in
the presence of 50 to 100 ^ug/ml of bovine albumin carrier, with
an equal volume of 1% CETAB (hexadecyltrimethylammonium bromide).
Fifteen minutes was allowed for complete precipitation to occur
before samples were filtered on 2 A cm glass fiber filters and
washed with distilled water. Samples were dried and 2.0 ml of
scintillation fluid (5 gm of Packard Pre-Kix "P" in one liter of
toluene) was added for counting in a Series 3000 Packard Tricarb
Liquid Scintillation Counter.
Lysates from an in vivo experiment were diluted 10"1 in the
trls-EDTA buffer. 0.10 ml of each sample was very carefully lay-
ered onto a 5% to V?% sucrose gradient in the same buffer. Samples
were centrifuged for 90 minutes at 35,000 rpm (100,000 g) at IS C.
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Fractions were collected, precipitated, and filtered as above. In
sonic cases 0.2 ml of 35 was added to each fraction, arc 0.1 ml of
each fraction was put onto a glass fiber filter, cried, and counte< .
From an in vivo experiment, a 0.13 ail sample of each lysate
which had been treated with urea and ether extracted was carefully
layered onto a 8 ml gradient of £% to V?% sucrose in tris-EDTii
buffer formed on a 3.5 ml layer of 30;i sucrose in a 9/l6 x 3 • inch
nitrocellulose tube. The gradients were e'entrifuged for 135 min-
utes at 35,000 (150,000 g) at 18 C in SW ^1 rotor in a 3eckman,
Model 12-50, ultracentrifuge. A hole was punctured in the bottom
of the tube with a § 25 guage needle. Six drops per fraction were
collected. The first **8 drops corresponding to the 30^ sucrose lay-
er were discarded. 0.2 ml of SS was added to each fraction. 0.1
ml from each fraction was put on a glass fiber filter, dried, and
assayed for radioactivity. 0.1 ml of each fraction was added to
competent cells to be assayed for transforming activity.
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RESULTS
The Effects of Actinomycin on Transformation
In some experiments, the ability of MMS-treated cells to re-
pair alkylated DM in the presence of actinomycin was assayed as
the ability of the DNA from these cells to transform competent
cultures of B. subtilis
. It was necessary to determine the effect
of actinomycin on transformation in order to distinguish a reduc-
tion in transforming activity of the DM due to damage induced by
MS from a reduction caused by the effect of actinomycin on trans-
formation.
1.6 ^x-g/ml of actinomycin reduces the number of transformants
obtained from a competent culture of B. subtilis 168H ind "* being
transformed by 8.0^g/ml of DM from B. subtilis 1-123 ind"1" (Table 1),
If actinomycin is added to DM at the same time as the competent
cells, the number of transformants is reduced to 0.2^ of those
obtained when competent cells are transformed by 8.0,^g/ml of DM
alone (i.e., control), if actinomycin is added 3 minutes after the
competent cells have been added to the DM, the number of trans-
formants increases from 0.2^ to 0A% of the control, in contrast,
if 200^ug/ml of DMase is added to 8.0 ^og/ml of transforming DM
at the same time as the competent cells, no transformants occur.
If DNase is added 3 minutes after the competent cells have been
added to the DM, the number of transformants increases to 7,0%
of the control (see Material and Methods, section e, p 20).
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. : 1. The Effects on Transformation of Actinomycin
Added at Various Times after Transformation Se/rlns
erlal Time of
Addition
Pinal Gel]
Dilution' 1
imber of
Transformation/ml
ilative
Frequency'3
None
-2.
10
io-3
10
848 x IO2
81 x 10 3
7 x IO4
Average 8.3 x IO 21 1.0
>. se 15' Before io"
1
o
DNase 0' Before
-1
10
B;:ase 3« Afterd
_1
10
-2
10
6 16 x 101
57 x IO
2
Average 5.9 x 10 3 .07
Actinomyclr o' Before io"
1
_2
10
9 x 10
1
3 x 10
2
Average 1.9 x IO2 .002
Actinomyoir 3'After
-1
10- 16 x 10
1
-2
10 . 5 x io
2
Average 3.3 x io
2
.00^
Actinomyclr 10 'After
-2
10 160 x IO
2
10~3 14 x IO 3
Average 1.5 x 10 .18
ipetent cells were diluted and plated on C'd after transformation.
ilative to the untreated sample.
^Before competent cells are added to transforming DNA.
- fter competent cells are added to transforming DNA.
In conclusion, if DNase or actinomycin is added to br> reform-
ing DNA the the same time as the competent cells, DNAse 1:.
effective than actinomycin in reducing transformation. If either
of these substances is added 3 minutes after competent cells hove
been added to the transforming DNA, actinomycin is about 20 times
more effective than DNase in inhibiting transformation. This sug-
gests that the effect of actinomycin is more than an immediate
halt in the uptake of DNA by competent cells. Otherwise, the
number of transformants obtained when actinomycin is added 3
minutes after competent cells have been added to DNA should be
equal to or greater than the number obtained when D::ase is added
3 minutes after the competent cells have been added to DNA. Since
the reverse is true, actinomycin must affect some other aspect of
transformation besides the ability of the competent cells to take
up DNA.
Since the number of transformants increases as the time of
addition of actinomycin to transforming DNA and competent cells is
delayed, the effect of actinomycin on transformation must be more
than just a general lethal affect on any cell growing in its pre-
sence. The frequency of transformation is 18$ of control if ac-
tinomycin is added 10 minutes after competent cells have been added
to the transforming DNA. If actinomycin is added to the control
sample after transformation has occurred but before the cells are
plated on CH without further dilution, very few cells will grow.
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If 0.1 ml of a 10
-
dilution is plated, the number of tranformants
obtained is equal to that of the control sample plated prior to the
addition of actinomycin.
In a similar experiment, 10./*g/ml or 2.7>*g/ml of actinomycin
was added to whole cells of B. suhtllls 168H lnd +thv~ prior to
lysis (See Material and Methods, Section e, p 20). Without fur-
ther purification, each of these lysates was diluted, and each
dilution was assayed for transforming activity. As a control,
lysates of cells which had been lysed without actinomycin were
also assayed for transforming activity. The results are shown in
Table 2.
If the lysate is not diluted sufficiently before being assayed
for transforming activity, actinomycin inhibits transformation.
?or example, if the lysate containing 2.7x<g/ml of actinomycin is
diluted 1,000-fold, or until the final concentration of actinomycin
is 0.0027^g/ml, there is very little inhibition of transformation
compared to that of control lysates lacking actinomycin but diluted
to the same extent. If the dilution is only 100-fold, or until the
final concentration of actinomycin is 0. 027^x^/^.1, the transforma-
tion frequency is only lk% of a 100-fold dilution of the control
lysate. A lysate containing 10^ug/ml must be diluted 10,000-fold,
or until the final concentration of actinomycin is 0.001>x.T/;nl,
-2 .
before there is no inhibition of transformation. A 10 (0.1^-,^/ml
_3
of actinomycin) and 10 (0.01^ug/ml of actinomycin) yield 6,.i and
b*?% t respectively. From this experiment it was concluded that at
a concentration of 2.7^tg/ml of actinomycin, any reduction of trans-
forming activity in experimental lysates would reflect a result of
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! damage and not an effect of actinomycin, if a 10 dilution
of lysate was .assayed. As a precaution in all experiments, various
dilutions of lysate from untreated (control) cells lysed in the
presence of actinomycin v:as always assayed for transforming ac-
tivity. The dilution of this lysate which did not yield reduced
transforming activity was considered a valid dilution to use for
assaying the experimental lysates which contained actinomycin.
To determine T.-xhat effect actinomycin might have on growing
cells, 2.7-og/ml of actinomycin was added to a log-phase culture
of B. subtilis l68H. The culture was assayed for viable cells
at various times thereafter. The results are shown on Table 3.
Although actinomycin seems to prevent the cells from dividing when
it is present in a culture up to one hour, it is not lethal to
these cells. After actinomycin is diluted out of a culture, cell
growth resumes (i.e., colonies appear after overnight growth on N3S)
This result is In agreement with the transformation experiment
cited above. When actinomycin is added to a control sample con-
taining transforming DMA and competent cells which have been re-
acted together for 30 minutes (a period of time sufficient for
complete transformation), no inhibition of transformation occurs.
This is observed only if the transformed cells are diluted before
being plated on CH. Note also (Table 1) that in samples contain-
ing actinomycin, the number of transformants obtained is consistent-
ly smaller at the 10" cell dilution (0.1 ml plated directly on CH)
-2 -3
than at 10 or 10 dilutions.
In conclusion, actinomycin inhibits transformation, but this
J"
TABLE 3. The Effect of Actinomycin on Growing Cells
?ime of Assay'
a Viable Cell Count
minutes 2.9 x 10 S
10 minutes 3.2 x 10 8
20 minutes k.2 Bx 10
30 minutes 3.6
o
x 10
Jj-0 minutes 3.7 x 10
8
6o minutes k.l x i08
aThe time the assay sample was taken after actinomycin
had been added to the culture.
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effect may be avoided if the actinomycln is diluted sufficiently
before transformation begins.
DNA Treated with MMS In Vitro
There is a nuclease active in extracts of 3. subtilis which
specifically inactivates DNA methylated by MMS. When transforming
DNA is alkylated with 0.012 M MMS for 30 minutes at 37 C and
treated with an extract from 3. subtilis (see Material and Methods,
section h, p 23), there is a hundred-fold drop in transform!!
activity compared to less than a two-fold drop in that of non-
alkylated (control) DMA treated with the same extract (Table 4).
The presence of 2.7>«g/ml of actinomycln does not inhibit the
inactivation of alkylated DNA by this enzyme. If DMA is incubated
with actinomycln for 15 minutes before being treated with MMS and
then the enzyme, inactivation still occurs.
Figure 1 shows the degradative effect of enzyme treatment on
DNA. Non-alkylated DMA and non-alkylated DMA treated with the
extract band in the same position when centrifuged on 5.7 /i to
17.6$ sucrose gradients (see Material and Methods, section k, p 26),
Alkylated DMA, alkylated DMA + actinomycln, and DMA incubated with
actinomycln and then treated with MMS all band at the same position
as control (non-alkylated) DNA. The three alkylated DNA samples
all shift to a position of lower molecular weight after treatment
with the extract (Fig's. 1 and 2). This shift is the expected
consequence of nuclease activity on alkylated DNA. Since this
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TABLE 4. Treatment of Alkylated D^TA with a 3. subtilis Extract,
?D vitro. in the presence and Absence of Actlnomycin
• o.
1
2
1
2
1
2
Relative Transforming Activity2
Expt. Control
1.0
1.0
KKS-DNA
0.19
0.56
Control •
Extract
Control + Control + Actlnomycin
Actlnomycin
I
+ Extract
0.59
0.^3
1.3 O.56
MMS-DNA +
Extract i
0.0023
0.075
KMS-DNA +
Actlnomycin
KKS-DNA + Actlnomycin
+ Extract
0.27
0.28
0.005
0.0^5
Actlnomycin- Actinomycin-EITA +
DKA + MMS KMS + Extract
0.23 0.06
Relative to the control DMA in each experiment.
"DMA that has not been treated with MMS.
aDMA that has been treated with MMS..
DMA that has been incubated with actlnomycin prior to treatment
with MMS.
PLATE I
The effect of an enzyme extract of 3. subtilis 168H on the
molecular weic-ht of DNA and of DMA alkylated with MMS -orior
to treatment with the extract. .0—6, DNA; O--0 DNA
treated with the extract; A A, MMS-treated DNA; *--•£,
MMS-treated D^A treated with the extract (See Material and
Methods, section h, p 23). Samples were centrifuged on
5.7 * to 17.6,1 sucrose gradients at 35,000 rpm for 2 hours
at 13 C (see Material and Methods, section k, p 26).
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PLATS II
The effect of an enzyme extract of B. subtilis 168H on the
molecular weight of DM alkylated with MMS and then incubated
with actinomycin prior to enzyme treatment and of DM incubated
Kith actinomycin and alkylated with MMS prior to enzyme
treatment. O—O , DNA incubated with actinomycin prior to
treatment with MMS; O--O
,
DM incubated with actinomycin,
th en treated with MMS prior to treatment with the enzyme;
A A
,
DNA treated with MMS prior to incubation with actin-
omycin; A a, DNA treated with MMS, then incubated with
actinomycin prior to enzyme treatment; X X, DM. treated
with MMS (see Material and Methods, section h, p 23).
Samples were centrifured on 5.7% to 17,6% sucrose gradients
at 35,000 rpm for 2 hours at 18 C (see Material and Methods,
section k, p 26)
.
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shift occurs, It Is clear that actihomycln does not inhibit, the
alkylatlon of DNA in vitro , nor does it inhibit the nuclease
activity of the enzyme on alkylated DKA.
DMA Treated with MMS In Vivo
The extent of DKA inactivation produced by treating cells
with MS may be determined by lysing the treated cells and com-
paring the transforming activity of the DNA from these cells with
that of the DNA from cells of the same culture which have been
removed prior to treatment and lysed in the same manner.
Alkylated DKA (i.e., methylated DKA) is a substrate for a
nuclease present in E. subtilis
. This nuclease degrades alkylated
DKA during the time the cells are being lysed to extract their DNA,
If the number of 'methylated bases (i.e., enzyme substrates) have
been reduced prior to lysis by cellular repair processes, the
amount of degradation that occurs during lysis is equally reduced
(Heiter and Strauss, 1965). The degraded DKA does not act as
transformi:- A. Thus, it is possible to determine whether repair
has occurred during the incubation after KMS treatment.
As seen in Table 5, the transforming activity of DNA in lysates
of cells lysed immediately after treatment with 0.025 K KKS for
5 minutes at 3? C (see Material and Methods, section i, p 24) is
0.6% of the transforming activity in lysates of untreated cells.
..'hen the treated cells are incubated for 50 minutes prior to lysis,
there is a 15-to 20-fold increase in the transforming activity of
the DM.
1'rO
When treated cells .urn chilled so that they cannot repair
lesions and 2.7„/Ag/ml of actlnomycln is added to the culture
prior to lysis, the transforming activity in this lysate Is 3,0%
of that in lysates of untreated cells (control). In other words,
if treated cells are lysed in the presence of actlnomycln, the
transforming activity of this lysate (3*0$ of control) is 5 tines
higher than that obtained from a lysate of treated cells lysed
in the absence of actlnomycln (0.6,6 of control). Apparently
actir.omycin alone is able to increase the transforming activity
of treated cells under conditions which prevent cellular repair
processes from functioning. 3ut this transforming activity is not
as high as that occurring in a lysate of treated cells which have
been incubated in growth medium + 2.7/^g/ml of actlnomycln for
50 minutes prior to lysis. The transforming activity of this
lysate is 8.0% of control, or 2 to 3 times higher than the activ-
ity in the lysate of treated cells lysed in the presence of actln-
omycln immediately after treatment.
In summary, repair of KKS-induced damage seems to occur in
the presence of actlnomycln as measured by an increase in trans-
forming activity In lysates of treated cells which have been in-
cubated in growth medium plus actlnomycln prior to lysis. This
repair is not so dramatic when transforming activity is compared
to that from a lysate of treated cells in which repair was pre-
vented, but actinomycin was also present during lysis. This is
true for two reasons: (l) because transforming activity In lysates
of treated but non-recovered cells lysed in the presence of ac-
tinomycin is 5 times greater than the transforming activity In
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•; 5. recovery of B. subtilln 168H from MMS Treatment
Treatment
^-
Surviving
Fr.nctiona
N/K
Recovery
Period
'. Relative Tran
s
-Actinomycin
forming Activity13
+ Actinomycin
KMS 3efore
Aotinomyclr
Was Added
.003 None
50 min.
.004
.04
.01
.03
.06 None
50 min.
.0004
.06
.015
.075
.5 None
50 min.
.041
.22
.06
.14
MS After
Actinomycin
Was Added
.14
-•'one
50 min.
.02
.42
.08
.09
a^,
^rviying fraction of MMS-treated cells compared to untreated
'Relative to the extractable transforming activity from controlcultures not treated with MMS. Control cultures tS? we°elysed in the presence of actinomyoin had essentially the' sanetransforming activity as control cultures lysed alone
PLATE III
Molecular weight studies on DNA from cells treated with MMS
prior to lysis. o o
, MMS-treated cells lysed immediately
(M ); o o, MMS-treated cells lysed immediately ir. the
presence of actinomycin (M + Act. D) ; A A , MMS-treated
cells which were incubated in growth medium prior to lysis
(KR); A A, MHS-treated cells which were incubated in
rrowth medium containing actinomycin prior to lysis (MR +
Act. D) ; X—X, untreated cells lysed in the absence of
actinomycin (Control); X— -x, untreated cells lysed in the
presence of actinomycin (Control + Act. D). Samples were
centrifuged on $% to V?% sucrose gradients at 35, 000 rpm
for 90 minutes at 18 C (see Material and Methods, section k,
p 26).
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lysates of treated but non-recovered cells lysed In the abser
of actinomycln; and (2) because the transforming activity of
lysates from treated cells recovered in the presence of actlnonycin
is 1.3 times less than the transforming activity of lysates of
treated cells recovered in the absence of actinomycin. The pres-
ence of actinomycin seems to cause an increase in the transforming
activity in lysates of treated, non-recovered cells and a decrease
in transforming activity In lysates of treated, recovered cells.
In these experiments, transformation activity was assayed at a
dilution of the lysates in which there was no inhibition of trans-
formation as determined from lysates of untreated cells lysed in
the presence of actinomycin. Therefore, any effect of actinomycin
was not on transformation per se .
If 2.7 jug/ml of actinomycin is added to cells 10 minutes
before treatment with 0.01 M MS, there is no increase In trans-
forming activity in a lysate of these treated cells which have
been incubated for 50 minutes at 37 C in growth medium plus ac-
tinomycin prior to lysis compared to that in lysates of KKS-treated
cells pre-incubated with actinomycin but lysed immediately after
treatment in the presence of this antibiotic (Table 5). The trans-
forming activity from both of these lysates is ^ times higher than
that from a lysate of treated, non-recovered cells lysed in the
absence of actinomycin and 5 times less than that from a lysate
of treated cells recovered and then lysed in the absence of ac-
tinomycin. This suggests that repair does not occur if actinomycin
is added to cells prior to treatment with MS, although actinomycin
does cause an increase In the transforming activity of both of these
lysates
.
Molecular Weight Studies on DMA Treated
with ----- In ;/ivo
The molecular weights of DNA from treated cells lysed "both In
the presence and absence of actinomycin have been compared to
those of DMA from treated cells which were incubated in growth
medium both in the presence and absence of actinomycin prior to
lysis. When samples of the lysates are centrifu^ed on Si° to 1?.
sucrose rradients (Material and Methods, section k, p 26 ) differ-
ences in molecular weights of the DNA can be seen (Pig. 3). Treat-
ed but unrepaired DNA bands at a position indicative of a smaller
molecular weight in comparison to untreated (control) DMA. As
expected, repaired DNA from incubated cells bands at a position
intermediate of control and unrepaired DMA. Surprisingly enough,
the DMA in lysates of cells recovered and lysed in the presence of
actinomycin and the DMA in lysates of non-recovered cells lysed
in the presence of actinomycin both band at a position nearly the
same as the control DMA. Actinomycin itself increases the effective
molecular weight of untreated DNA slightly. If actinomycin is
added to control cells, the DMA from this lysate will band con-
sistently at a slightly lower position, one fraction, than control
- alone. This slight difference is within the ranp:e of error
for this particular technique.
*5
In an unpublished experiment Reiter (personal coiamunication)
has demonstrated the same result. If actinomycln is added to
extracted DM and centrifuged in either a sucrose gradient con-
taining the same concentration of actinomycin or In a sucrose
gradient without actinomycin, the actinomycin-DM complex will
band at a position which is one fraction lower than control DHA
without actinomycin.
These data are not able to account for the greater difference,
3 to b fractions, obtained when DM from KKS-treated cells recov-
ered in the presence of actinomycin is compared to the DM from
treated cells recovered alone, or when DM from non-recovered cells
lysed in the presence of actinomycin is compared to DM from non-
recovered cells lysed alone (Pig. 3).
DM from both the lysate of the recovered cells in actinomycin
(i.e., treated cells which have been both incubated and lysed in the
presence of actinomycin) and the lysate of the non-recovered cells
in actinomycin (i.e., treated cells which have been lysed in the
presence of actinomycin immediately after treatment) have increased
molecular weights which are nearly equal to the DM from a lysate
of untreated cells. Also, there is a smaller difference in
transforming activity between these two lysates than in that
between lysates of recovered and non-recovered cells lacking actin-
omycin. Therefore, it seemed possible that the DM from the cells
recovered in actinomycin was not really being repaired. The two
to three-fold difference in transforming activity of this lysate
and the lysate from non-recovered cells lysed in actinomycin could
be due to the increased concentration of actinomycin inside the
recovered cells as a result of a 50 minute incubation period at
37 C before lysis.
The effect of actinomycin on molecular weight and transformir
activity of DNA could be due to an inhibition of the alkylated-
DNA-speclfic nuclease, or possibly due to the preservation of the
physical integrity of the DNA, in spite of nuclease activity,
as a result of actinomycin interacting with DNA and, perhaps, pro-
tein. From the in vitro studies it is clear that actinomycin does
not inhibit the activity of the nuclease in extract form. But it
is possible that the DNA-actinomyoin interaction is more complex
lH vivo a^<3 can inhibit enzyme activity, or that the activity of
the enzyme is altered as a result of extraction. The best avail-
able method for answering both of these questions seemed to be by
dissociating the actinomycin-DNA complex, removinr the actinomycin,
and determining the molecular weight of the DNA. If the nuclease
had been effective at the time of lysis, the molecular weight of
the DNA should decrease, now banc in? at higher positions in a
sucrose gradient. If this were true, it would now be possible to
determine whether repair had occurred during incubation by com-
paring the positions of recovered and non-recovered samples which
had been dissociated from actinomycin.
Urea is capable of removing actinomycin from DNA at concen-
trations (approximately 5 M) which are not disruptive to the DNA
molecule itself (Hartman, Coy, and Kniese, 1963). The actinomycin
may then be removed by extraction with ether. Figure k shows the
effect of just ether extraction and the effect of urea treatment
and ether extraction on control DNA from untreated cells lysed
PLATS IV
Molecular weight studies on DMA from untreated cells lysed
in the presence or absence of actinomycin. The lysates were
treated with ether alone, or with urea first and then ether
(see Material and Methods, section j, p 25). Samples were
dialysed in tris-EDTA buffer and then centrifusred'on 5/i to
17% sucrose gradients at 35,000 rpm for 135 minutes at IB C
(see Material and Methods, section k, p 27). O—O t DNA
from untreated cells (Control); O— o , DMA from untreated
cells that has been treated with ether (Control + Ether);
O O
f DMA from untreated cells that has been treated
with urea and then ether (Control + Urea + Ether); A a,
DMA from untreated cells lysed in the presence of actinomycin
(Control + Act. D) ; A— A, DMA from untreated cells lysed in
the presence of actinomycin that has been treated with ether
(Control + Act. D + Ether); A -A, DNA from untreated cells
lysed in the presence of actinomycin that has been treated
with urea and then ether (Control + Act. D + urea + Ether).
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PLATS V
Molecular weight studies of DMA from MMS-treated cells that
has been treated with urea and extracted with ether (see
Material and Methods, section i, p 2h\ section j, p 25).
o o
,
DNA from MMS-treated cells lysed Immediately (MQ );°—0
f DNA from MMS-treated cells lysed Immediately in the
presence of actinonycin (Mb + Act. D) ; o o
, DNA from
MMS-treated cells lysed immediately in the presence of ac-
tinomycin that has been treated with urea and extracted
with ether (M + Act. D + Urea + iither); A A, DNA from
MMS-treated cells incubated in growth medium prior to lysis
(MR); A— A, DNA from MMS-treated cells incubated in growth
medium containing actlnomycin prior to lysis (MR + Act. D)
;
A A, DNA from MMS-treated cells incubated in growth
medium containing actlnomycin prior to lysis that has been
treated with urea and extracted with ether (MR + Act. D t
Urea + Ether). Samples were centrifu^ed in 5% to 17a sucrose
gradients at 35.000 rpm for 135 minutes at 18 C (see Material
and Methods, section k, p 27).
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alone and on control DNA from untreated cells lysed in the pres-
ence of actinomycin (see Material and Methods, section j, P'25).
It is apparent that this treatment has essentially no effect en
the molecular weight of DNA per se
.
DNA from treated cells recovered and then lysed in actinomycin
and DNA from treated, non-recovered cells lysed in actinomycin
were treated with urea and extracted with ether. The DNA fron
each of these lysates now bands at a new position (Fig. 5).
It is clear that the DNA from the treated cells recovered and
lysed in actinomycin now bands at the position of repaired DNA;,
whereas the DNA from treated, non-recovered cells lysed in actin-
omycin is approaching the position occupied by non-repaired DNA.
The slight difference in molecular weight between this sample and
that of the non-repaired DNA may be due to residual actinomycin
on the DNA from these treated, non-recovered cells lysed in the
presence of actinomycin, or possibly due to a partial interference
with nuclease activity at the time of lysis.
In conclusion, actinomycin does not seem to inhibit the repair
of KKS-induced DNA damage occurring1 during the incubation period
in growth medium after treatment, or the activity of the nuclease
specific for alkylated DNA which acts at the time of lysis in MMS-
treated cells. Actinomycin does cause an increase in the molecu-
lar weight of DNA from both treated cells lysed immediately and
treated cells incubated prior to lysis. This must be due to some
interaction of actinomycin with DNA and, perhaps, protein.
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Survival Curves for MMS-Treated
B. subtllls 16 8H and 3. subtllls #40 mms"
The differences in survival of E. subtllls 16311 and 3. subtllls
#40 rams" after treatment with MMS can be seen in Figure 6. It
should be noted that the survival curve for #4-0 jams" is determined
at a dose which is one half of that given for inactivation of
16 8H (0.025 M instead of 0.C5 K MMS), Under these conditions
(see Material and Methods, section f, p 22), the survival curve
for B. subtllls #40 mms has a slight shoulder, extrapolating to
k. The survival curve for B. subtilis 168H extrapolates to 1.0,
suggesting one-hit kinetics. The slope for B. subtilis 168H
changes at higher doses, whereas the slope for the survival curve
for B. subtilis ifkQ mms" remains constant throughout the highest
doses tested. From these results it is clear that this strain is
more sensitive to MMS than 168H is.
DNA from B. subtilis #40 mms" Treated
with MMS In Vivo
A culture of 3. subtilis #k0 mms " was treated with O.OO56 M
MMS for k minutes at 3? C. A sample of the treated culture was
incubated in growth medium for 50 minutes at 37 G prior to lysis.
Another sample of the treated culture was lysed immediately after
treatment. These lysates were assayed for transforming activity
(see Material and Methods, section i, p 24).
PLATS VI
Survival curves for MMS-treated cultures of B. subtilis 168H
and B. subtilis f-kO m%ns~ (see Material and Methods, section i
p 22T. r.. subtilis 168H was treated with 0.05 K MS and
B. subtili s
--r%0 irczs " was treated with 0.025 M MMS. Assay
samples were diluted and plated on NBS.
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PLATE 3ZE
o B. sublilis 168 H
A B. subtiiis #40mms
20 30
TIME (MINUTES)
40 5Ti 60
V-
The transforming activity of lysates of recovered cells is
about h- times greater than that of lysates of non-recovered cells
(Table 6). In other words, some repair is occurring after KMS-
treatment in this sensitive strain, but it is not as great as
that occurring in a MMS-treated culture of B. subtllis 168H.
A lysate of treated cells of B, subtills ;'/k0 mr.s " which
have boon incubated and lysed in the presence of actlnomyclr; has
only 2 times more transforming activity than a lysate of treated
cells lysed immediately in the presence of actinomycin (Table 6).
The transforming activity of this lysate (of treated, non-
recovered cells lysed in actinomycin) is the same as that of a
lysate of treated, non-recovered cells lysed alone. On the other
hand, DNA in a lysate of treated cells recovered and lysed in the
presence of actinomycin has 2 times less transforming activity
than the DNA in a lysate of treated cells recovered and lysed
alone. Again, actinomycin seems to decrease the transforming
activity of lysates of recovered cells incubated and lysed in its
presence. In this case, it did not affect the transforming
activity of lysates of non-recovered cells lysed in its presence
compared to that of lysates of non-recovered cells lysed in its
absence.
By observing the intensity of color in pellets of centrifuged
cells, it was apparent that more actinomycin was present in the
I IMS
-treated cells that were incubated in growth medium containing
actinomycin for 50 minutes after treatment than in the cells that
were diluted into ice-cold SS containing actinomycin immediately
I",
6. Recovery of B. subtilis #40 mm
a'fter EMS Treatment
Treatment Surviving
Fraction '
N/1 o
Recovery
Period
Relative Transformin 3 Activity15
- Actinomycin + Actir.omycin
HMS Before
Actinomycin
Was Added
.027 None
50 min.
.10
.44
.06
.11
.039 -one
50 min.
.06
.28
.08
.13
.04 None
50 min.
.16
• 72
.19
.41
After
Actinomy-
cin Was
Added
.04 None
50 min.
.33
.6
.5
.5
.03? None
50 min.
.14
.4
.2
.27
aSurviving fraction of I :::3- treated cells compared to untreated
cells.
Relative to the extractable transforming activity from control
cultures not treated with KKS. Control cultures that were
lysed in the presence of actinomycin had essentially the" same
transforming activity as control cultures lysed alone.
after MKS treatment. It is possible that the transfo act-
ivities of these lysates might be equivalent if the final con-
centration of aotinomycin was equivalent In both samples. To
avoid this difference in concentration, 2.7 x*~/ml of aotinomycin
was added to the cells 10 minutes prior to treatment With MKS.
After treatment one sample was lysed immediately in the same con-
centration of aotinomycin. Another sample was incubated for 50
minutes at 37 C in the same concentration of aotinomycin and then
lysed as usual. The results of two experiments are shown in
Table 6. There is no difference in the transforming activity of
DNA in lysates of recovered and non-recovered cells when both
are incubated with aotinomycin prior to MI-IS treatment. These
results can be compared to the transforming activity from corres-
ponding lysates of cells which have been treated with the same
dose of HKS but lysed in the absence of aotinomycin. On the
average, the transforming activity of the DNA from recovered cells
which have been incubated in aotinomycin prior to MMS treatment 1.3
times less than the transforming activity of the DKA from recovered
cells incubated without aotinomycin. The transforming activity of
DNA from non-recovered cells incubated in actinomycin prior to
S treatment is 1.3 times more than the transforming activity of
D;CA from non-recovered cells treated and lysed in the absence of
actinomycin. These results are similar to those obtained for B.
subtilis 168H under the same conditions (Table 5). In both in-
stances, the transforming activities of the two lysates of HKS-
treated cells (recovered and non-recovered) pre-incubated in
actinomycln are equal and intermediate of that of treated cells
lysed immediately in the absence of actinomycln (non-recovere
and of treated cells incubated prior to lysis but in the absence
of actinomycln (recovered).
Especially for B. subtil is 168H, the transforming activity ;
lower than that normally obtained when treated cells are recovered,
but not pre-incubated, in the presence of actinomycln. Normally,
the transforming activity of lysates of recovered cells contain!
actinomycln is 1.3 times less than that of lysates of recovered
cells alone, ./hen recovered cells are incubated with actinomycln
prior to MMS-treatment, and then lysed, the transforming activity
of this lysate is 5 times less than that of lysates of recovered
cells a.lone (Table 5).
This suggests that repair is not occuring vrhen actinomycln is
added, to cells prior to MMS treatment. Also, the transforming
activity does not increase when cells incubated in actinomycln
prior to MMS treatment have been recovered in growth medium after
treatment. It would be interesting to disocciate the actinomycln
from the DNA and then compare the molecular weights of these
samples.
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DISCUSSION
The repair of DNA lesions induced by the monofunctlonal
alkylating agent, methyl methanesulfonate, is similar to the repair
of DNA lesions induced by UV light. After MMS treatment, E
synthesis stops for a period of time. During this period r.hon
there is not net. increase in DNA, breakdown of DNA into acid-
soluble fragments occurs along with the incorportaion of radio-
active thymidine as repair replication.
MMS repair differs from UV repair in that UV-sensitive mutants
are able to repair MMS damage. It is possible to visulize that
the same mechanism of repair may be invoked, but that the repair
of MMS damage may require one less step of this mechanism. There-
fore, mutants unable to carry out the first step of UV repair
(excise thymine dimers) are still capable of repairing MMS-induced
lesions, since excision is not required for the repair of this
type of damage. In agreement, MMS-sensltive mutants are unable to
repair UV-induced lesions. Although these mutants, presumably
defective in a later step of repair, may be able to excise thy-
mine dimers, they are still unable to complete the repair process.
MMS repair and UV repair differ in one other aspect. UV repair
is inhibited if actinomycin is present during the recovery period
after UV treatment. In contrast, repair of MMS damage seems to
occur under the same conditions.
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In B. subtllis there is a nuclease activated at the tine of
lysis which specifically degrades alkylated DM. Therefore, it
is possible to detect repair of DNA in MMS-treated cells as an
increase in extractable transforming activity after incubation
in growth medium. If MMS-treated cells are incubated in growth
medium containing actinomycin, the transforming activity of
DM from these cells is now greater than that of DM from Ms-
treated cells which are lysed immediately after treatment. This
suggests that the DM has been repaired (i.e., the methyl groups
have been removed) and the DM is no longer susceptible to the
nuclease specific for alkylated DM. This research was an effort
to study this particular aspect of MMS repair in greater detail.
The transformation activity of lysates of MMS-treated cells
lysed immediately, both in the presence and absence of actinomycin,
and of MMS-treated cells incubated prior to lysis, both in the
presence and absence of actinomycin, was determined. These data,
at first glance, suggest that repair has occurred both in the
presence and absence of actinomycin. The transforming activity
of lysates of recovered cells is about 20 times greater than that
of lysates of non-recovered cells. When actinomycin is present
during the recovery and lysis of MMS-treated cells, the transforming
activity of lysates of recovered cells is only 2-3 times greater
than that of non-recovered cells lysed in actinomycin. DM from
MMS-treated cells recovered in growth medium containing actinomycin
does not have as much transforming activity as DM from MMS-
treated cells recovered in growth medium without actinomycin
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(Pj of control versus 11 /o of control). This may be due to an effect
of actinornycin on transformation that is not apparent in lysates
for control (untreated) cells lysed in the presence of actinornycin.
Since control cells have not been incubated for 50 minutes at 3? C,
the concentration of actinornycin within these cells may be lower
than that of recovered cells. This difference may also be an in-
dication that repair is not as efficient in the presence of actin-
ornycin.
Transforming activity of DNA is higher in lysates of non-
recovered cells lysed in the presence of actinornycin than in lysates
of non-recovered cells lysed alone (3# of control versus 0.6$ of
control). Since actinornycin may be holding the DNA molecule intact
(see below), it is possible that the recipient organism is capable
of taking up this DKA, repairing it, and then being transformed.
In the UV repair system, repair of UV-damap-ed DNA does occur in
the recipient cell (Reiter and Strauss, 1965). Heiter also has
evidence that competent cells are able to take up DNA in the
presence of actinornycin at concentrations which are inhibitory
to transformation (personal communication). Another possible
explanation may be that degradation (thus inactivation of trans-
forming activity) by the nuclease specific for alkylated DNA may
not be as efficient in cells containing actinornycin.
Results from sucrose gradient centrifugation suggest that
the molecular weight is the same for DNA present in a lysate of
non-recovered cells lysed in the presence of actinornycin and for
DNA present in a lysate of cells recovered and lysed in the pre-
sence of actinornycin. The DNA in both lysates bands at a position
in sucrose gradients that is very close to the position of D A
from untreated cells. In contrast, DMA from non-recovered cells
lysed in the absence of actinomycin bands at a position near the
top of a sucrose gradient, indicating it has a smaller molecular
weirht. DNA from cells recovered in the absence of actinorr.ycir.
bands at a position intermediate of control and unrepaired E
From the above results, it is impossible to distinguish
between the possibility that actinomycin may be inhibiting the
nuclease specific for alkylated DNA or merely preserving the
physical integrity of the DMA molecule as a result of its attach-
ment to DNA. Since the molecular weight of the DMA in the samples
containing actinomycin is the same, it is also impossible to deter-
mine whether repair, measured as an increase in molecular weight
of repaired DMA compared to unrepaired DMA, has occurred in the
presence of actinomycin.
Native DNA in the B conformation is more efficient in binding
actinomycin (Reich, 196*0, and actinomycin complexed to DMA causes
an increase in the irreversible denaturation temperature (Reich,
1964; Haselkorn, 1964). This may be indirect evidence that actin-
omycin is attached in some way to the strand of DMA opposite to
the one containing guanine, which is bound to the quinoidal oxygen
of actinomycin by its N2 amino group (Reich and Goldberg, 1964).
Perhaps the peptide lactones, which are required to be intact for
complexing to occur (Reich and Goldberg, 1964), may be hydrogen
bonded to the opposite strand. There are four sites in the peptide
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lactones capable of forming hydrogen bonds (Reich and Gold* . ,
19(90. If the nuclease causes single-strand breaks in the DK/»
molecule, the attachment of actinomycln to both strands at tt
site of a single-strand break may prevent the opposite strand from
being broken at this fragile point. Alternatively, aotinomycin
could be responsible for holding together the two free ends re-
sulting from a single-strand break. Peptide lactones could again
be involved in this bonding. Since it is probable that all the
alkylated guanine moieties have actinomycln bound to them (see
below), either of the above possibilities could account for the
DNA molecule remaining intact, in spite of single-strand breaks
caused by the alkylated-DNA-sepcif ic nuclease.
There are an average of 4.26 lethal hits per locus if the
survival of transforming activity for the indole locus of non-
recovered cells is 0.014 compared to the transforming activity of
DNA from control cells (Table 5). Assuming that each lethal hit
is equivalent to a methylated guanine, there would be 1.3 x 10-*
methylated guanine residues per DNA molecule which is 3 x 10
base pairs long (McCarthy, I967). This is assuming that a single-
strand locus has a molecular weight of 3-5 x 10 daltons (Strauss,
Searashi and Bobbins, i960). Assuming one fourth of the bases to
be guanine, O.O87/0 of the guanines would be methylated. At the
concentrations of actinomycin used, there are 4 x 10 actinomycln
molecules available per DNA molecule. This would be 2.7 actinomycin
molecules per each guanine residue. Obviously, there would be a
100 % probability of B.r\ actinomycin molecule being attached to a
methylated guanine.
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The number of alkylated guanines would be higher if the nuc-
lease only caused single- strand breaks (Strauss, personal commun-
ication to Reiter). In this case, a lethal hit would be the re-
sult of a scission in the DNA molecule which occurred when two
single-strand breaks were closely located on opposite strands.
Assuming the probability of an alkylation occurring is the sane
on either strand, the probability of two alkylations being nearly
opposite would be 0.00087. From this, the probability of a guanine
on either strand being alkylated would be 0.03. Although the
assumption that the latter calculation is based on (that the
nuclease causes single-strand breaks) is probably the correct one,
there is still a very high probability that the alkylated moiety
will be attached to an actinomycin molecule (since there are 2.7
actinomycin molecules present per each guanine residue).
In conclusion, there was enough actinomycin present in these
experiments that each methylated guanine could be attached to a
molecule of actinomycin. This supports the hypothesis that
actinomycin is capable of preserving the physical integrity of
methylated DNA in spite of single-strand breaks caused by the
nuclease specific for DNA methylated at the site of guanine and,
perhaps, adenine residues. This would explain why the molecular
weight of DNA from both recovered and non-recovered cells lysed
in actinomycin is nearly the same as that of control DNA. It
also suggests an explanation for the fact that transforming activ-
ity is higher in lysates of non-recovered cells lysed in actinomy-
cin compared to that of lysates of non-recovered cells lysed
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alone (i.e., competent cells are able to take up this "intact"
DNA, repair it, and then be transformed). The second possible
explanation, that actinomycin prevents the nuclease from acting
on methylated DNA, could also account for the fact that the mole-
cular weight of DNA from both recovered and non-recovered cells
in actinomycin is nearly the same as control. It would be diffi-
cult to explain why the transforming activity of DNA from non-
recovered cells lysed in actinomycin is greater than that of D'lA
from non-recovered cells lysed alone, but not as great as that of
DNA from cells recovered and lysed in actinomycin
—unless con-
centration of actinomycin within the cell is a critical factor.
Studies on the effect of actinomycin on the nuclease in vitro
suggest that actinomycin does not inhibit the activity of this
enzyme. There is the same amount of reduction in transforming
activity if the samples of methylated-DNA, methylated-DKA incubated
with actinomycin, and DNA incubated with actinomycin prior to
methylation are treated with an extract of B. subtilis . Although
unlikely, it is possible that the activity of the enzyme is al-
tered as a result of extraction, and, in vivo
, inhibition of the
enzyme is occurring.
If these samples are centrifuged on sucrose gradients, it is
apparent that actinomycin does not prevent the degradation of
methylated-DNA by the nuclease. This is in contrast to the results
of in vivo studies. Perhaps the interaction of actinomycin and
DNA is more complex in vivo. The DNA used in in vitro studies
has been purified. Therefore, if another component (such as protein)
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is involved in the complex formed in, vivo , this would not be pro-
sent in the purified DMA.
To determine: 1) whether DNA from both recovered and non-
recovered cells lysed in actinornycin was degraded by the nuclease
at the time of lysis; and 2) whether DNA from cells recovered in
actinornycin was actually repaired; it is necessary to dissociate
the actinornycin from the DNA with 5 M urea, and remove it by re-
peated extractions with anhydrous ether. This treatment does not
alter the molecular weight of control DNA or control DNA completed
with actinornycin. As seen from sucrose gradient centrifugation,
there is a large decrease in the molecular weight of DNA from
both cells recovered and lysed in actinornycin and. non-recovered
cells lysed in actinornycin. Originally these DNA samples banded
at a position similar to that of control DNA. DNA from these
recovered cells now bands at the same position as repaired DNA
from treated cells which were recovered in the absence of actinorny-
cin, and the DNA from these non-recovered cells is approaching
the position of non-repaired DNA from treated cells lysed immediately
but in the absence of actinornycin. The fact that this DNA has not
reached the position of non-repaired DNA may be explained in two
ways; enough actinornycin may still be remaining on the DNA molecule
to partially hold it together; or the presence of actinornycin at
the time of lysis has prevented as complete a degradation by the
nuclease from occurring. It may be possible to test the first
possibility by determining a spectrograph of the sample. If
actinornycin is present there will be a change in absorption at
6k
kkO m^u (Cerami, et al, I967).
In conclusion, repair of MMS-induced damage to DNA does occur
in the presence of actinomycin. The transforming activity of
lysates of MMS-treated cells incubated in rrowth medium containing
actinomycin increases 2-3 fold over that of lysates of MMS-treated
cells lysed immdelately in actinomycin. When actinomycin is dis-
sociated from DKA, the molecular weight of DNA from cells recovered
in actinomycin decreases to that of repaired DNA. The molecular
weight of DM from non-recovered cells lysed in actinomycin decreases
to nearly that of unrepaired DKA. Repair, measured as an increase
in transforming activity after incubation in .growth medium, is
not as efficient in the presence of actinomycin. The transforming
activity of DKA from these cells is never as great as that from
MMS-treated cells incubated in growth medium without actinomycin.
It is not known for certain if this is an effect of actinomycin
on repair.
Earlier data have supported the hypothesis that the mechanism
for MMS repair is the same as that of UV repair, but with fewer
steps being utilized for MKB repair. Now it appears that at least
some of the repair of MMS damage must be different than that of
UV repair. UV repair, in contrast of MMS repair, is inhibited
by the presence of actinomycin. Also, UV repair requires repair
replication. When MMS-treated cells are being incubated in growth
medium containing actinomycin, repair occurs without the incor-
poration of 3H-thymidine. (Reiter, personal communication).
Another type of repair for MMS-induced damage can now be
hypothesized. An enzyme may be present which is capable of re-
moving the methyl group on the N7 of guanine without causing a
single-strand break in the sugar-phosphate backbone. It is possi-
ble that repair of apurinic sites caused by hydrolysis of the
methylated base from the ribose-phosphate backbone occurs via the
excision-repair mechanism. These lesions would not be repaired
in the presence of actinomycin. Both mechanisms may be function-
ing normally when actinomycin is not present, since the trans-
forming activity of DNA from MMS-treated cells recovered in its
absence is greater than the activity of that from MMS-treated cell:
recovered in its presence.
Another explanation involving methylated adenine moieties
may be considered. Adenine is methylated at the i\"3 position at
one-fourth the frequency of the methylation of guanine at 1'7
,
but it is released five times faster than 7-methyl guanine to
yield apurinic sites (Lawley, 1966). Since these methyl groups
would not be in the same position with respect to the DNA double
helix, an enzyme capable of recognizing the 7-methyl guanine and
removing the methyl group may not detect the 3-methyl adenine.
These lesions may require at least the latter steps of excision
and repair mechanism, if the apurinic sites were further hydro-
lyzed to yield single-strand breaks. This repair would be
inhibited by actinomycin.
Results of Treatment of B. subtllls #*K) mms " with M] .
Prom the results of the survival curves, it is apparent that
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2. suhtilis i;AO mmr: Is more sensitive to MKS than _. r;-;bt? 1 i n
168H. Originally this strain was unable to repair DMA d
induced by MMS but during this Investigation it was found th
this strain obtained a four-fold increase in transforming activity
after post-treatment incubation in growth medium. This is less
than half of the repair obtained by B. subtil In 168H under the
le conditions. In agreement with the results for 3. subtil 3 r.
168H, there was a decrease in transforming activity of DNA from
HMS-treated cells recovered in actinomycin compared to that for
DNA from MS-treated cells recovered in its absence. In this
case, the transforming activity of DNA from non-recovered cells
lysed in actinomycin was the same as that obtained for DNA from
non-recovered cells lysed in its absence. In this case, trans-
forming activity of DNA from recovered cells in actinomycin was
only two-fold higher than that of DNA from non-recovered cells
lysed in actinomycin.
It was originally planned to determine the molecular weight
distribution of DNA from treated cells unable to repair KKS damage,
both in the presence and absence of actinomycin. Since this
strain underwent some recovery, this problem was not continued.
It is interesting to note that when actinomycin was added to
these cells prior to treatment with KMS, the transforming activity
of DNA from recovered and non-recovered cells, both in the presence
of actinomycin, was equivalent (Table 6). Although the transfor
activity of the lysates of non-recovered cells lysed in actinomycin
was increased to even a greater extent compared to the transforming
6?
activity of lysatea of non-recovered cells alone, the s a aore
noteable decrease in the transforming activity of lysates of treat-
ed cells recovered in actinomyoin compared to that in lysates of
treated cells recovered alone.
The same type of results were obtained in an identical exper-
iment with B. subtilis 160H (Table 5). In this case, the trans-
forming activities of the lysates of both recovered and non-
recovered cells incubated with actinomycin prior to treatment
with MMS were equal and intermediate of the transforming activities
obtained for lysates of non-recovered cells and recovered cells,
both in the absence of actinomycin.
It appears that the repair of damage induced by MMS that
occurs in the presence of actinomycin may be inhibited if the
actinomycin is added early enough. Perhaps enzyme induction is
required for this type of repair. In other experiments, actinomy-
cin was added after MMS treatment, which requires k-5 minutes.
This is adequate time for enzyme induction to take place. This
"inducible" enzyme may be the one suggested earlier which is cap-
able of removing the methyl group from guanine without causing a
single-strand break in the sugar-phosphate backbone.
SUMMARY
1. Actinomycin inhibits transformation at concentrations £rea
than 1 x 10 J ^otg/ml. Apparently the effect is more co. .-
plex than inhibition of DNA uptake by competent cells.
2. Growing cells incubated in growth medium containing 2.7
^/g/ml of actinomycin for at least one hour at 37 c are not
killed, although the number of cells present does not
increase during this time.
3. Actinomycin does not inhibit methylation of DNA with methyl
methanesulfonat e
.
h. Actinomycin does not prevent DNA methylated In vitro with
MMS from being inactivated by a nuclease present In B.
subtllis extracts specific for methylated DMA. If meth-
ylated DNA is incubated with actinomycin prior to treatment
With the enzyme extract, the actinomycin does not preserve
the physical integrity of this DNA.
5. Actinomycin does not prevent repair of MMS-Induced damage to
DNA from occurring during post-treatment incubation of KKS-
treated cells in growth medium containing this antibiotic.
This repair is less than that normally occurring when MKS-
treated cells are incubated in growth medium without
actinomycin.
6. The presence of actinomycin at the time of lysis of MKS-
treated cells lysed immediately after treatment enhanced
the transforming activity of this lysate compared to that
'J
of MMS-treated colls lysed immediately, but In the absenc
of actinomycln.
7. Transforming activity of lysates of 1-2'IS-treated cells
recovered and lysed in tho presence of actlnomyclr Is less
than that of MMS-treated cells recovered and lysed Ir
absence of actinomycln.
8. If actinomycin is present in both recovered and non-recove
samples of MKS-treated cells, the original sixe (molecular
weight) of the DMA is preserved, in spite of tho presence
of single-strand breaks caused by the nuclease specific for
alkylated DMA that is activated at the time of lysis.
9. Dissociation of actinomycln from DMA by 5 H urea results in
a decrease in molecular weight of DMA from KMS-treated cells,
both non-recovered and recovered samples, lysed in the pre-
sence of actinomycin. The molecular weight of DMA from the
treated cells recovered and lysed in actinomycin is no::
equivalent to that of repaired DMA. The molecular weight
of DMA from treated, cells lysed immediately in actinomycin
is now nearly equivalent to that of unrepaired DMA.
10. If actinomycin is added to cells prior to treatment with ...3,
repair does not occur. Transforming activities of lysates
of both recovered and non-recovered samples of this culture
are equal and intermediate of the transforming activities of
lysates of non-recovered cells and recovered cells alone.
11
• -• subtllis #*K) mms" is more sensitive to MIIS than B. subtili:
168H. Although repair occurs in this strain, it is less than
half of that occurring in B. subtll is 168H.
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ABSTRACT
A nuclease present in Bacillus subtills degrades ethylated
at the time of cell lysis. Since the degraded DNA does lot
act as transforming DNA, repair may be measured, as an increase in
transforming activity of DNA from MMS-treated cells incubated in
growth medium prior to lysis compared to that of MMS-treated ceils
lysed immediately.
A culture of 3. subtilis 168H was treated with a monofunc-
tional alkylating agent, methyl methanesulfonate. Two samples of
this culture were lysed immediately after treatment; one in tris-
EDTA buffer containing actinomycin and the other in tris-EE
buffer only. A third, sample of the treated culture was recovered
in growth medium plus actinomycin, and a fourth sample was
recovered in growth medium only.
Transforming activities of these lysates shoved that altho
repair occurs in the presence of actinomycin, it is less efficient
than normal repair. Molecular Xfeight studies indicated that ac-
tinomycin inhibits degradation of methylated. DNA in both recovered
and non-recovered cells, although the transforming activity of the
DNA has been inactivated by the nuclease. Dissociation of actino-
mycin from DNA with 5 M urea showed that the DNA had actually
been degraded by the nuclease but was being held intact in the
presence of actinomycin. DNA from non-recovered cells now bands
at a position in sucrose gradients indicative of a small molec-
ular weight. It is nearly equivalent to the molecular weight
of unrepaired DNA from MMS-treated cells lysed immediately after
treatment, but in the absence of actinomycin. DMA from recovered
colls now bands at an intermediate position in sucrose gradients
identical to that of repaired DMA from MMS-treated cells recovered
in Bcrowth medium in the absence of actinomycin prior to lysis.
From these data it was concluded that repair of KMS damage does
occur in the presence of actinomycin.
If actinomycin is added to cells prior to treatment with MMS,
repair apparently does not occur. The transforming activity of
lysates of both recovered and non-recovered cells from this culture
are identical and intermediate to the transforming activities of
lysates of recovered and non-recovered cells to which actinomycin
was not added. This suggests that the enzyme responsible for
repair of HKS-induced damage (at least that occurring in the
presence of actinomycin) is inducible rather than constitutive.
